Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D00OCV
|
||||
Former ID |
DNC005855
|
||||
Drug Name |
3-(2-Dimethylamino-ethyl)-2-methyl-1H-indol-4-ol
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [527668] | ||
Structure |
Download2D MOL |
||||
Formula |
C13H18N2O
|
||||
Canonical SMILES |
CC1=C(C2=C(N1)C=CC=C2O)CCN(C)C
|
||||
InChI |
1S/C13H18N2O/c1-9-10(7-8-15(2)3)13-11(14-9)5-4-6-12(13)16/h4-6,14,16H,7-8H2,1-3H3
|
||||
InChIKey |
HXNGZUVNHQYMKL-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | 5-hydroxytryptamine 2A receptor | Target Info | Inhibitor | [527668] | |
5-hydroxytryptamine 2C receptor | Target Info | Inhibitor | [527668] | ||
WikiPathways | Serotonin Receptor 2 and STAT3 Signaling | ||||
Serotonin Receptor 2 and ELK-SRF/GATA4 signaling | |||||
SIDS Susceptibility Pathways | |||||
Monoamine GPCRs | |||||
GPCRs, Class A Rhodopsin-like | |||||
Gastrin-CREB signalling pathway via PKC and MAPK | |||||
GPCR ligand binding | |||||
GPCR downstream signaling | |||||
GPCRs, OtherWP732:Serotonin Receptor 2 and ELK-SRF/GATA4 signaling | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.